According to Invitae 's latest financial reports the company's current EPS (TTM) is -$3.23. In 2022 the company made an earnings per share (EPS) of -$13.35 a decrease over its 2021 EPS that were of -$1.71.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.23 | -75.81% |
2022 | -$13.35 | 680.7% |
2021 | -$1.71 | -61.14% |
2020 | -$4.40 | 67.94% |
2019 | -$2.62 | 32.32% |
2018 | -$1.98 | -25.28% |
2017 | -$2.65 | -12.54% |
2016 | -$3.03 | -8.73% |
2015 | -$3.32 | 23.76% |
2014 | -$2.68 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Celldex Therapeutics CLDX | -$2.40 | -25.70% | ๐บ๐ธ USA |
HTG Molecular Diagnostics
HTGM | -$23.41 | 624.77% | ๐บ๐ธ USA |
CareDx CDNA | -$1.56 | -51.70% | ๐บ๐ธ USA |